#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Laryngeal squamous cell carcinoma Rosai-Dorfman syndrome Fatty acid oxidation disorder Leukoencephalopathy Chronic myeloid leukaemia (in remission) Chronic myeloid leukaemia Hyperadrenocorticism Malformation venous Myelodysplastic syndrome with excess blasts Anal fistula Dupuytren's contracture Selective polysaccharide antibody deficiency Antithrombin III deficiency Blastic plasmacytoid dendritic cell neoplasia Hypersensitivity pneumonitis More trials…

    Learn about Rare Diseases

    Fragile X syndrome – Basic Information Glomerulonephritis membranoproliferative – Life with Disease Angiosarcoma non-metastatic – Life with Disease Erdheim-Chester disease Lymphangiosarcoma – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Chondrosarcoma metastatic – Basic Information VEXAS syndrome – Trials in Disease Hairy cell leukaemia – Diagnostics Lymphangiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mitotane Carvedilol Levothyroxine Dfv890 Immunoglobulins, Normal Human Specific Nucleic Acid Sna-Xfsc Fipaxalparant Ezabenlimab Sildenafil Citrate 204-NETU Mb-Cart20.1 Terbinafine Hydrochloride Amphotericin B Tradipitant Sabestomig Abc-24F-116 Trastuzumab Emtansine Citicoline Sodium Escitalopram L-Ascorbic Acid More therapies…

    Learn about Your Condition

    Cerebrovascular accident Becker's muscular dystrophy Angiosarcoma non-metastatic Skin neoplasm excision Demyelination Rasmussen encephalitis Osteosarcoma Breast cancer metastatic Overweight Metastatic malignant melanoma Alcohol use disorder Status epilepticus Myxofibrosarcoma Malignant oligodendroglioma Vesicoureteric reflux More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effect of Clopidogrel and Acetylsalicylic Acid on Reducing Heart and Blood Vessel Events in Patients with Peripheral Arterial Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Peripheral artery angioplasty
    • Peripheral artery restenosis
    • Peripheral artery stenosis
    Investigated Drugs:
    • Lactose Monohydrate
    • Acetylsalicylic Acid
    • Clopidogrel
    The Netherlands

  • Study on Botulinum Toxin for Patients with Degenerative Rotator Cuff Tendinopathy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Tendon disorder
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    France

  • Study on the Effect of Norepinephrine Infusion for Managing Low Blood Pressure in Patients Undergoing Non-Cardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural hypotension
    Investigated Drugs:
    • Norepinephrine
    Poland

  • Study on the Effectiveness of EHSG-KF Skin Graft for Patients with Deep Partial and Full-Thickness Burns

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
    Belgium France Germany Italy The Netherlands Poland +2

  • Study on the Effectiveness of Apixaban for Pain Relief in Patients with Venous Malformations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Arteriovenous malformation
    Investigated Drugs:
    • Apixaban
    Norway

  • Study on the Effects of Stopping Alendronic Acid in Patients with Osteoporosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Alendronic Acid
    • Tetracycline Hydrochloride
    Denmark
Previous Page
1 … 317 318 319 320 321 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!